NRG Oncology/NSABP B-51/RTOG 1304: Phase III trial to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to breast RT post breast-conserving surgery (BCS) reduces invasive breast cancer recurrence free interval (IBCRFI) in patients (pts) with positive axillary (PAx) nodes who are ypN0 after neoadjuvant chemotherapy (NC).
Year: 2016
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Eleftherios P. Mamounas, Hanna Bandos, Julia R. White, Thomas B. Julian, Atif J. Khan, Simona Flora Shaitelman, Mylin Ann Torres, Frank Vicini, Patricia A. Ganz, Susan Ann McCloskey, Soonmyung Paik, Nilendu Gupta, X. Allen Li, Dominic J. DiCostanzo, Joseph P. Costantino, Walter John Curran, Norman Wolmark
Institutions: Orlando Health, NRG Oncology, University of Pittsburgh, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Allegheny General Hospital, Rutgers Cancer Institute, The University of Texas MD Anderson Cancer Center, Emory University, Winship Cancer Institute, Trinity Health Oakland Hospital, University of California, Los Angeles, Yonsei University, The Ohio State University, Medical College of Wisconsin, The Ohio State University Wexner Medical Center
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4240890048